View in EDS HTML Full Text PDF Full Text

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.

Saved in:
Bibliographic Details
Title: From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Authors: Bosch D; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. Dianne.Bosch@radboudumc.nl., van der Velden KJM; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Haarlem, The Netherlands., van den Berg HP; Department of Medical Oncology, Tergooi Medical Center, Hilversum, The Netherlands., Bergman AM; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., van der Doelen MJ; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands., Kerkhofs TMA; Division of Medical Oncology, Department of Internal Medicine, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., van de Luijtgaarden ACM; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tascilar M; Department of Medical Oncology, Isala, Zwolle, The Netherlands., Vervenne WL; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands., Weijl NI; Department of Medical Oncology, Haaglanden Medical Center, The Hague, The Netherlands., Uyl-de Groot CA; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Mulders PFA; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Kuppen MCP; Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., van Oort IM; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 183-192. Date of Electronic Publication: 2026 May 09.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42105061
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bosch+D%22">Bosch D</searchLink>; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. Dianne.Bosch@radboudumc.nl.<br /><searchLink fieldCode="AU" term="%22van+der+Velden+KJM%22">van der Velden KJM</searchLink>; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Beeker+A%22">Beeker A</searchLink>; Department of Medical Oncology, Spaarne Gasthuis, Haarlem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Berg+HP%22">van den Berg HP</searchLink>; Department of Medical Oncology, Tergooi Medical Center, Hilversum, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bergman+AM%22">Bergman AM</searchLink>; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Doelen+MJ%22">van der Doelen MJ</searchLink>; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Eertwegh+AJM%22">van den Eertwegh AJM</searchLink>; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hendriks+MP%22">Hendriks MP</searchLink>; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kerkhofs+TMA%22">Kerkhofs TMA</searchLink>; Division of Medical Oncology, Department of Internal Medicine, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Luijtgaarden+ACM%22">van de Luijtgaarden ACM</searchLink>; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mehra+N%22">Mehra N</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Moorselaar+RJA%22">van Moorselaar RJA</searchLink>; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tascilar+M%22">Tascilar M</searchLink>; Department of Medical Oncology, Isala, Zwolle, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vervenne+WL%22">Vervenne WL</searchLink>; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Weijl+NI%22">Weijl NI</searchLink>; Department of Medical Oncology, Haaglanden Medical Center, The Hague, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Uyl-de+Groot+CA%22">Uyl-de Groot CA</searchLink>; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mulders+PFA%22">Mulders PFA</searchLink>; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuppen+MCP%22">Kuppen MCP</searchLink>; Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Oort+IM%22">van Oort IM</searchLink>; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101658456%22">Drugs - real world outcomes</searchLink> [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 183-192. <i>Date of Electronic Publication: </i>2026 May 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101658456 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2199-1154 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221989788%22">21989788 </searchLink><i>NLM ISO Abbreviation: </i>Drugs Real World Outcomes <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42105061
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40801-026-00548-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 183
    Titles:
      – TitleFull: From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bosch D
      – PersonEntity:
          Name:
            NameFull: van der Velden KJM
      – PersonEntity:
          Name:
            NameFull: Beeker A
      – PersonEntity:
          Name:
            NameFull: van den Berg HP
      – PersonEntity:
          Name:
            NameFull: Bergman AM
      – PersonEntity:
          Name:
            NameFull: van der Doelen MJ
      – PersonEntity:
          Name:
            NameFull: van den Eertwegh AJM
      – PersonEntity:
          Name:
            NameFull: Hendriks MP
      – PersonEntity:
          Name:
            NameFull: Kerkhofs TMA
      – PersonEntity:
          Name:
            NameFull: van de Luijtgaarden ACM
      – PersonEntity:
          Name:
            NameFull: Mehra N
      – PersonEntity:
          Name:
            NameFull: van Moorselaar RJA
      – PersonEntity:
          Name:
            NameFull: Tascilar M
      – PersonEntity:
          Name:
            NameFull: Vervenne WL
      – PersonEntity:
          Name:
            NameFull: Weijl NI
      – PersonEntity:
          Name:
            NameFull: Uyl-de Groot CA
      – PersonEntity:
          Name:
            NameFull: Mulders PFA
      – PersonEntity:
          Name:
            NameFull: Kuppen MCP
      – PersonEntity:
          Name:
            NameFull: van Oort IM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2199-1154
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Drugs - real world outcomes
              Type: main
ResultId 1